DEVELOPMENT OF DRUG RESISTANCE TO RIFAMPICIN

被引：26
|
作者：
MANTEN, A
VANWIJNG.LJ
机构：
来源：
CHEMOTHERAPY | 1969年 / 14卷 / 02期
关键词：
D O I：
10.1159/000220615
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：93 / &
相关论文
共 50 条
  • [41] Rifampicin mono-resistant Mycobacterium tuberculosis in Bujumbura, Burundi:: results of a drug resistance survey
    Sanders, M
    Van Deun, A
    Ntakirutimana, D
    Masabo, JP
    Rukundo, J
    Rigouts, L
    Fissette, K
    Portaels, F
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2006, 10 (02) : 178 - 183
  • [42] Emergence of primary drug resistance to rifampicin in Mycobacterium leprae strains from leprosy patients in India
    Lavania, M.
    Nigam, A.
    Turankar, R. P.
    Singh, I.
    Gupta, P.
    Kumar, S.
    Sengupta, U.
    John, A. S.
    CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (12) : E85 - E86
  • [43] The impact of drug resistance on Mycobacterium tuberculosis physiology: what can we learn from rifampicin?
    Koch, Anastasia
    Mizrahi, Valerie
    Warner, Digby F.
    EMERGING MICROBES & INFECTIONS, 2014, 3
  • [44] PHARMACOKINETIC DRUG-INTERACTIONS WITH RIFAMPICIN
    VENKATESAN, K
    CLINICAL PHARMACOKINETICS, 1992, 22 (01) : 47 - 65
  • [45] Susceptibility of Legionella species to five antibiotics and development of resistance by exposure to erythromycin, ciprofloxacin, and rifampicin
    Nielsen, K
    Bangsborg, JM
    Hoiby, N
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 36 (01) : 43 - 48
  • [46] DNA FINGERPRINTS OF MYCOBACTERIUM-TUBERCULOSIS DO NOT CHANGE DURING THE DEVELOPMENT OF RIFAMPICIN RESISTANCE
    GODFREYFAUSSETT, P
    STOKER, NG
    SCOTT, JAG
    PASVOL, G
    KELLY, P
    CLANCY, L
    TUBERCLE AND LUNG DISEASE, 1993, 74 (04): : 240 - 243
  • [47] Tigecycline-Rifampicin Restrains Resistance Development in Carbapenem-Resistant Klebsiella pneumoniae
    Shi, Shiyi
    Xu, Mengxin
    Zhao, Yining
    Feng, Luozhu
    Liu, Qi
    Yao, Zhuocheng
    Sun, Yao
    Zhou, Tieli
    Ye, Jianzhong
    ACS INFECTIOUS DISEASES, 2023, 9 (10): : 1858 - 1866
  • [48] RIFAMPICIN: ANTI TUBERCULAR DRUG: AN OVERVIEW
    Bhoi, Nutan Shriram
    Ola, Monika
    Bhaskar, Rajveer
    Sathe, Nilesh Suresh
    Kute, Vaibhav Ghansham
    Patil, Rajeshwari Satish
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (05): : 9585 - 9595
  • [49] DRUG-COMBINATIONS AND THE BIOAVAILABILITY OF RIFAMPICIN
    ACOCELLA, G
    TUBERCLE AND LUNG DISEASE, 1992, 73 (04): : 242 - 244
  • [50] Lichenoid drug eruption associated with rifampicin
    Ladhari, C.
    Fathallah, N.
    Mokni, S.
    Sriha, B.
    Ben Salem, C.
    PRESSE MEDICALE, 2018, 47 (03): : 281 - 282
12345